U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT07481526) titled 'A Prospecitve Multicenter, Observational Registry Study' on Feb. 13.

Brief Summary: This is a prospective, multicenter, observational registry study designed to collect data to deepen the understanding of CKD therapeutics, changes in clinical practice, cardiorenal risk outcomes and differences in treatment approaches in Chinese CKD patients.

Study Start Date: Feb. 27

Study Type: OBSERVATIONAL

Condition: Chronic Kidney Disease

Recruitment Status: RECRUITING

Sponsor: AstraZeneca

Disclaimer: Curated by HT Syndication....